Oncology
Pediatric Hematologist, Oncologist & Bone Marrow Transplant Specialist5 Years of Experience in Pediatric Hematology Oncology and Bone Marrow Transplantation
HCG Cancer Hospital, K R Road
Bangalore
Dr. Amit Galgali is a Pediatric Hematologist, Oncologist and Bone Marrow Transplant specialist in Bengaluru with 5 years of experience in managing childhood cancers, blood disorders and conditions requiring stem cell or bone marrow transplantation.
His clinical expertise includes childhood leukemias such as Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia, lymphomas and pediatric solid tumours including osteosarcoma, Ewing sarcoma, neuroblastoma, Wilms tumour, retinoblastoma, rhabdomyosarcoma and soft tissue sarcomas.
Dr. Amit Galgali also manages non-malignant pediatric blood disorders such as thalassemia, sickle cell anemia, immune thrombocytopenia, hemophilia, autoimmune hemolytic anemia and other forms of pediatric anemia.
He is experienced in performing autologous and allogeneic blood and bone marrow transplantation for pediatric malignancies as well as selected benign hematological disorders such as thalassemia and sickle cell disease.
Dr. Amit Galgali completed his MBBS and MD in Paediatrics followed by specialised fellowship training in Paediatric Haemato Oncology and Bone Marrow Transplantation. His approach focuses on comprehensive, evidence-based and child-centred cancer and hematology care.
Childhood leukemia treatment is planned according to the specific leukemia subtype, risk category and overall health of the child, with close monitoring throughout therapy.
ALL is one of the most common childhood blood cancers and requires structured pediatric oncology treatment based on disease risk, response to therapy and individual clinical factors.
Pediatric AML treatment involves specialised haemato-oncology care and may include intensive therapy and bone marrow transplantation in selected high-risk or relapsed cases.
Childhood lymphoma treatment is selected according to the lymphoma type, stage and biological characteristics, with multidisciplinary pediatric oncology follow-up.
Osteosarcoma treatment usually requires coordinated pediatric oncology and orthopedic oncology care, with systemic treatment and local tumour management planned according to disease stage.
Ewing sarcoma requires multimodal cancer treatment based on tumour location, stage and response to therapy, with ongoing pediatric oncology monitoring.
Neuroblastoma treatment is based on age, tumour biology, disease stage and risk classification, with advanced treatment considered for high-risk disease when appropriate.
Wilms tumour is a childhood kidney cancer managed through coordinated pediatric oncology care according to tumour stage, pathology and treatment response.
Retinoblastoma requires specialised multidisciplinary care aimed at controlling the tumour while preserving vision and the eye whenever clinically possible.
Rhabdomyosarcoma treatment depends on tumour location, stage and risk classification and requires coordinated pediatric oncology management.
Bone marrow transplantation may be considered for selected childhood cancers and blood disorders when replacing diseased or damaged blood-forming cells is clinically appropriate.
Autologous transplantation uses the child's own previously collected stem cells to restore bone marrow function after intensive treatment.
Allogeneic transplantation uses healthy blood-forming stem cells from a suitable donor and may be used for selected malignant and non-malignant blood disorders.
Thalassemia management includes long-term hematology care and, in selected eligible children, consideration of curative treatment through bone marrow transplantation.
Sickle cell anemia requires ongoing hematology care to manage complications and may involve transplantation in appropriately selected patients.
Immune thrombocytopenia requires evaluation of platelet levels, bleeding risk and clinical symptoms to determine the most appropriate management strategy.
Hemophilia care focuses on preventing and controlling bleeding episodes through specialised pediatric hematology management and appropriate replacement treatment.
Autoimmune hemolytic anemia requires evaluation and treatment to control immune-mediated destruction of red blood cells and manage associated anemia.
MBBS, MD (Paediatrics), Fellowship in Paediatric Haemato Oncology and BMT
Bone Marrow Transplantation, Autologous Bone Marrow Transplantation, Allogeneic Bone Marrow Transplantation, Childhood Leukemia Treatment, Acute Lymphoblastic Leukemia (ALL) Treatment, Acute Myeloid Leukemia (AML) Treatment, Pediatric Lymphoma Treatment, Osteosarcoma Treatment, Ewing Sarcoma Treatment, Neuroblastoma Treatment, Wilms Tumor Treatment, Retinoblastoma Treatment, Rhabdomyosarcoma Treatment, Soft Tissue Sarcoma Treatment, Thalassemia Management, Sickle Cell Anemia Management, ITP Management, Hemophilia Management, Autoimmune Hemolytic Anemia Management, Pediatric Anemia Management
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Amit Galgali
Yes. HCG lists thalassemia and sickle cell anemia among his areas of interest, including bone marrow transplantation for appropriately selected children with these disorders.
His documented expertise includes osteosarcoma, Ewing sarcoma, neuroblastoma, Wilms tumor, retinoblastoma, rhabdomyosarcoma and other pediatric soft tissue sarcomas.
Yes. Dr. Amit Galgali is experienced in both autologous and allogeneic blood and bone marrow transplantation for selected pediatric malignancies and benign blood disorders.
Yes. HCG specifically documents Dr. Amit Galgali's experience in treating pediatric Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia along with other hematological malignancies.
Dr. Amit Galgali's qualifications include MBBS, MD in Paediatrics and Fellowship training in Paediatric Haemato Oncology and Bone Marrow Transplantation.
Contact us for personalized help or to schedule an appointment.